SARS‐CoV‐2 re‐infection risk in Austria-Reference-Cited by-同舟云学术

SARS‐CoV‐2 re‐infection risk in Austria

Published:2021-02-21 Issue:4 Volume:51 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur. J. Clin. Invest.

Author:

Pilz Stefan¹^ORCID,Chakeri Ali²,Ioannidis John PA³^ORCID,Richter Lukas²,Theiler‐Schwetz Verena¹,Trummer Christian¹,Krause Robert⁴,Allerberger Franz²

Affiliation:

1. Division of Endocrinology and Diabetology Department of Internal Medicine Medical University of Graz Graz Austria

2. Austrian Agency for Health and Food Safety (AGES) Vienna Austria

3. Departments of Medicine, Epidemiology and Population Health Biomedical Data Science, and Statistics and Meta‐Research Innovation Center at Stanford (METRICS) Stanford University Stanford CA USA

4. Section of Infectious Diseases and Tropical Medicine Medical University of Graz Graz Austria

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13520

Reference28 articles.

1. Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly

2. Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic

3. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

4. Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

5. Reinfection With SARS-CoV-2: Implications for Vaccines

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the risk of SARS-CoV-2 reinfection with the Omicron or Delta variant in Wales, UK;PLOS ONE;2024-09-06

2. Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis;Frontiers in Public Health;2024-06-20

3. Dissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infection;Infectious Diseases;2024-06-13

4. Investigation of epidemiological and clinical characteristics of people infected with SARS-CoV-2 during the second pandemic of COVID-19 in Chengdu, China;Frontiers in Public Health;2024-05-01

5. Modeling viral evolution: A novel SIRSVIDE framework with application to SARS-CoV-2 dynamics;hLife;2024-05